Susanna Gatti High - Net Worth and Insider Trading
Susanna Gatti High Net Worth
The estimated net worth of Susanna Gatti High is at least $5 Million dollars as of 2024-06-06. Susanna Gatti High is the COO of Dyne Therapeutics Inc and owns about 154,062 shares of Dyne Therapeutics Inc (DYN) stock worth over $5 Million. Susanna Gatti High is also the COO of bluebird bio Inc and owns about 13,735 shares of bluebird bio Inc (BLUE) stock worth over $12,607. Details can be seen in Susanna Gatti High's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Susanna Gatti High has not made any transactions after 2024-05-16 and currently still holds the listed stock(s).
Transaction Summary of Susanna Gatti High
Susanna Gatti High Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susanna Gatti High owns 2 companies in total, including Dyne Therapeutics Inc (DYN) , and bluebird bio Inc (BLUE) .
Click here to see the complete history of Susanna Gatti High’s form 4 insider trades.
Insider Ownership Summary of Susanna Gatti High
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DYN | Dyne Therapeutics Inc | 2024-05-16 | Chief Operating Officer |
BLUE | bluebird bio Inc | 2018-12-06 | Chief Operating Officer |
Susanna Gatti High Latest Holdings Summary
Susanna Gatti High currently owns a total of 2 stocks. Among these stocks, Susanna Gatti High owns 154,062 shares of Dyne Therapeutics Inc (DYN) as of May 16, 2024, with a value of $5 Million and a weighting of 99.75%. Susanna Gatti High also owns 13,735 shares of bluebird bio Inc (BLUE) as of December 6, 2018, with a value of $12,607 and a weighting of 0.25%.
Latest Holdings of Susanna Gatti High
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DYN | Dyne Therapeutics Inc | 2024-05-16 | 154,062 | 32.78 | 5,050,152 |
BLUE | bluebird bio Inc | 2018-12-06 | 13,735 | 0.92 | 12,607 |
Holding Weightings of Susanna Gatti High
Susanna Gatti High Form 4 Trading Tracker
According to the SEC Form 4 filings, Susanna Gatti High has made a total of 11 transactions in Dyne Therapeutics Inc (DYN) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Dyne Therapeutics Inc is the sale of 2,738 shares on May 16, 2024, which brought Susanna Gatti High around $77,403.
According to the SEC Form 4 filings, Susanna Gatti High has made a total of 0 transactions in bluebird bio Inc (BLUE) over the past 5 years. The most-recent trade in bluebird bio Inc is the sale of 1,875 shares on December 6, 2018, which brought Susanna Gatti High around $198,206.
Insider Trading History of Susanna Gatti High
- 1
Susanna Gatti High Trading Performance
Susanna Gatti High Ownership Network
Ownership Network List of Susanna Gatti High
Ownership Network Relation of Susanna Gatti High
Susanna Gatti High Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Susanna Gatti High is the Chief Operating Officer of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include See Remarks Oxana Beskrovnaya , See Remarks Richard William Scalzo , and Chief Medical Officer Wildon Farwell .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Susanna Gatti High made 10 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 53,617. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 244,099 shares made by Jonathan Mcneill , a net sale of 194,534 shares made by Richard William Scalzo , and a net sale of 133,322 shares made by Oxana Beskrovnaya .
In summary, during the past 3 months, insiders sold 733,732 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 733,732 shares. During the past 18 months, 5,516,515 shares of Dyne Therapeutics Inc (DYN) were sold and 3,583,447 shares were bought by its insiders, resulting in a net sale of 1,933,068 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Susanna Gatti High Mailing Address
Above is the net worth, insider trading, and ownership report for Susanna Gatti High. You might contact Susanna Gatti High via mailing address: 75 Lorimer Road, Belmont Ma 02141.